Hilmar Bischoff - Concepedia

Author

Hilmar Bischoff

Bayer (Germany)

Also Known As

H Bischoff, H. BISCHOFF, H. Bischoff, H.-P. Bischoff, Hilmar BISCHOFF, Hilmar Bischoff, P. Thieblot

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Bayer (Germany)Architecture et Fonction des Macromolécules Biologiques Centre National de la Recherche Scientifique Institut de Pharmacologie et de Biologie Structurale Bayer (United States)

About

Hilmar Bischoff is an author at Bayer (Germany) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1K
2	Biochemistry	11	11	1K
3	Natural Sciences	6	6	377
4	Health Sciences	5	5	593
5	Chemical Biology	2	2	118

Hilmar Bischoff

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Pharmacology of alpha-glucosidase inhibition. Hilmar Bischoff PubMed GlycobiologyDietary FibreExperimental PharmacologyMolecular PharmacologyMetabolic Syndrome	1994	253
The mechanism of alpha-glucosidase inhibition in the management of diabetes. Hilmar Bischoff PubMed Insulin SignalingOxidative StressMetabolic SyndromeAlpha-glucosidase InhibitionAcarbose Delays	1995	235
Crystal structures of human pancreatic α-amylase in complex with carbohydrate and proteinaceous inhibitors Virginie Nahoum, Geneviève Roux, Pierre Rougé, Biochemical Journal GlycobiologyMolecular BiologyPeptide ScienceEnzymatic ModificationTrestatin Family	2000	133
Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor Hilmar Bischoff, Rolf Angerbauer, Joachim Bender, Atherosclerosis OxysterolBiochemistryMedicineLipid PeroxidationPharmacotherapy	1997	109
Crystal structures of human pancreatic alpha-amylase in complex with carbohydrate and proteinaceous inhibitors. Virginie Nahoum, Geneviève Roux, Pierre Rougé, PubMed Glucose ResidueBiochemistryNatural SciencesEnzyme CatalysisGlycobiology	2000	92
Enzyme-Catalyzed Condensation Reaction in a Mammalian α-Amylase. High-Resolution Structural Analysis of an Enzyme−Inhibitor Complex Minxie Qian, Virginie Nahoum, J. Bonicel, Biochemistry	2001	76
The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor S.E. Zographos, Nikos G. Oikonomakos, Katerina E. Tsitsanou, Structure BiochemistryPotent InhibitorNatural SciencesMolecular BiologyGlycogen Phosphorylase B	1997	75
Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the α‐glucosidase inhibitor acarbose Stefan Frantz, Laura Calvillo, Jochen Tillmanns, The FASEB Journal Oxidative StressMetabolic SyndromeAtherosclerosisCardiologyDyslipidemia	2005	68
Allosteric inhibition of glycogen phosphorylase <i>a</i> by the potential antidiabetic drug 3‐isopropyl 4‐(2‐chlorophenyl)‐1,4‐dihydro‐1‐ethyl‐2‐methyl‐pyridine‐3,5,6‐tricarboxylate Nikos G. Oikonomakos, Katerina E. Tsitsanou, S.E. Zographos, Protein Science Allosteric InhibitionGlycogen MetabolismBiochemistryNatural SciencesMedicine	1999	43
Minor structural modifications convert a selective PPARα agonist into a potent, highly selective PPARδ agonist Stefan Weigand, Hilmar Bischoff, Elke Dittrich‐Wengenroth, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologySelective Pparδ AgonistBiochemistryFunctional SelectivityMedicine	2005	28

Page 1